Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD1579 in Acne Vulgaris
NCT02073461Phase 2Completed
- Sponsor
- Galderma
- Start
- Mar 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of benzoyl peroxide in acne vulgaris (3 arms), sponsored by Galderma. Primary endpoint: Percent Changes From Baseline in Total Lesion Counts at 12 weeks. Started Mar 2014; status: completed.
02
Drugs
benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02073461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02073461.